NOX 8.33% 11.0¢ noxopharm limited

Ann: December 2023 Quarterly Activities Report and Appendix 4C, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 387 Posts.
    lightbulb Created with Sketch. 37
    I didn't see anywhere in Noxopharm that we are working on Lupus, what has been said is that our technology can also be used to look at lupus treatment in the future but at present we are not working on as far as i am aware. But what i am aware of is that Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.